Google plans to release a set of new AI models for drug discovery as part of its Health AI Developer Foundations program.
The TxGemma models are designed to understand natural language and the structural complexities of therapeutic entities, enabling targeted questions and predictions of critical properties of potential therapies.
The open nature of these models is expected to foster innovation and accelerate research, although commercial use and customization have not been confirmed.
Google's initiative aligns with its commitment to collaborate with the scientific community, aiming to revolutionize drug discovery with more efficient and accurate predictions.